When NK-92 cells were cocultured with NK-92-resistant cells at NK-92:target ratio of 1:1, about half of the population was CD56-positive (corresponding to NK-92 cells) and the other half was CD56-negative (corresponding to breast cancer cells). Here, NCAM1 is linked to breast cancer.